Looking for a peptide CDMO you can trust? JYMed Peptide has devoted 15+ years to one focus: peptide science. From three cGMP campuses in Shenzhen, Hubei, and Guangdong, more than 600 team members, including over 100 scientists and 12 PhDs, work inside 7 000 m² of purpose built laboratories to transform ideas into IND ready drug candidates and commercial scale APIs. Our track record speaks loudly: 2 900 CRO projects completed, more than 50 CDMO programs delivered, and clients holding six ANDAs and six INDs accepted by the FDA.

What this means for you: our spotless audit history across FDA, ICH, EDQM, and NMPA inspections keeps your submissions on schedule. Ten peptide API lines inside a 54 000 m² facility already ship more than 4 tons each year, and an expansion in progress will lift capacity beyond 10 tons by 2027 while adding 30 000 L of SPPS and LPPS reactor volume. Continuous chromatography, real time PAT, and DoE driven process development translate into higher yields, quicker turnarounds, and lower cost of goods.

Need difficult chemistry handled with confidence? Whether your project requires a 30 to 60 amino acid payload, a lipidated or glycosylated analog, a cyclic loop, or any other complex modification, our equipment and expertise make it routine. An end to end digital MES and an integrated QC suite including HPLC, UHPLC, LC MS, and MALDI TOF protect data integrity from gram scale route scouting to multiton validation lots.

In summary: JYMed Peptide unites deep peptide knowhow, proven regulatory fluency, and true industrial scale. With one accountable partner you move from discovery sample to commercial supply faster, with fewer surprises, and with quality you can trust.